| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 1504 |
| 1 | INFLIXIMAB-DYYB | 1205 |
| 2 | PREDNISONE | 1192 |
| 3 | AZATHIOPRINE | 512 |
| 4 | METHOTREXATE SODIUM | 430 |
| 5 | ACETAMINOPHEN | 407 |
| 6 | METHOTREXATE | 402 |
| 7 | HYDROCORTISONE | 395 |
| 8 | MESALAMINE | 384 |
| 9 | HYDROCORTISONE ACETATE | 381 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 1205 | 0.3497 |
| 1 | ANEMONE PATENS | 1 | 0.0667 |
| 2 | ADALIMUMAB-RYVK | 18 | 0.0165 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 120 | 0.0144 |
| 4 | AZATHIOPRINE SODIUM | 36 | 0.0142 |
| 5 | MESALAMINE | 384 | 0.0136 |
| 6 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI | 1 | 0.0130 |
| 7 | MILTEFOSINE | 5 | 0.0129 |
| 8 | METHYLENE BLUE | 20 | 0.0127 |
| 9 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 4 | 0.0116 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2614 |
| 1 | Corticosteroid [EPC] | 1655 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 551 |
| 3 | Purine Antimetabolite [EPC] | 512 |
| 4 | Azole Antifungal [EPC] | 434 |
| 5 | Aminosalicylate [EPC] | 426 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 401 |
| 7 | Anti-epileptic Agent [EPC] | 353 |
| 8 | Benzodiazepine [EPC] | 317 |
| 9 | Mood Stabilizer [EPC] | 294 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 5 | 0.0129 |
| 1 | Provitamin D2 Compound [EPC] | 204 | 0.0069 |
| 2 | Purine Antimetabolite [EPC] | 512 | 0.0052 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 63 | 0.0049 |
| 4 | Rifamycin Antimycobacterial [EPC] | 15 | 0.0043 |
| 5 | Aminosalicylate [EPC] | 426 | 0.0042 |
| 6 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 7 | Opioid Antagonist [EPC] | 3 | 0.0031 |
| 8 | Echinocandin Antifungal [EPC] | 23 | 0.0028 |
| 9 | Azole Antifungal [EPC] | 434 | 0.0028 |